Cipla, Sanofi India shares gain on distribution agreement
Cipla will be responsible for the distribution of Sanofi India’s six central nervous system products, including Frisium, a leading brand in the anti-epileptic medication category
Stay updated with breaking news from Cipla Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla will be responsible for the distribution of Sanofi India’s six central nervous system products, including Frisium, a leading brand in the anti-epileptic medication category
On March 27, the Indian stock market is expected to have a volatile opening as a result of mixed global cues. The...
Consumer discretionary major Titan Co saw 22% revenue growth for the third quarter ended December. The growth was broad-based as most of the segments put up a healthy performance during the quarter.
ScPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Analyst Recommendations This is a summary of recent ratings […]
ScPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Volatility and Risk scPharmaceuticals has a beta of 0.17, […]